Intrinsic Value of S&P & Nasdaq Contact Us

Zai Lab Limited ZLAB NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CN • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.00
+59.4%

Zai Lab Limited (ZLAB) generated $-150.79M in operating cash flow for fiscal year 2025. After capital expenditures of $8.1M, free cash flow was $-158.89M.

Free cash flow margin was -34.5% of revenue. Cash conversion ratio was 0.86x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (55/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was 0.86x suggests some earnings are non-cash items

Overall SharesGrow Score: 61/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
61/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
55/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
10/100
→ Income
Zai Lab Limited Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-150.79M$-150.79M$-214.87M$-198.18M$-367.64M
Capital Expenditure $-8.1M$-8.1M$-5.66M$-8.49M$-24.98M
Free Cash Flow $-158.89M$-158.89M$-276.39M$-206.67M$-392.63M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message